[HTML][HTML] The history of leishmaniasis

D Steverding - Parasites & vectors, 2017 - Springer
In this review article the history of leishmaniasis is discussed regarding the origin of the
genus Leishmania in the Mesozoic era and its subsequent geographical distribution, initial …

Leishmaniasis: where are we and where are we heading?

S Sasidharan, P Saudagar - Parasitology research, 2021 - Springer
Leishmaniasis is a zoonotic disease in humans caused by the bite of a parasite-infected
sandfly. The disease, widely referred to as “poor man's disease,” affects millions of people …

Recent updates and perspectives on leishmaniasis

D Savoia - The Journal of Infection in Developing Countries, 2015 - jidc.org
Leishmaniasis is a neglected vector-borne tropical infection considered to be a disease of
the poor. Concentrated in poverty-stricken countries within Southeast Asia, East Africa, and …

Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing

SS Braga - European Journal of Medicinal Chemistry, 2019 - Elsevier
This mini-review focuses on leishmanicidal drugs that were sourced from small molecules
previously approved for other diseases. The mechanisms of action of these molecules are …

[HTML][HTML] Surveillance of leishmaniasis cases from 15 European centres, 2014 to 2019: a retrospective analysis

G Van der Auwera, L Davidsson, P Buffet… - …, 2022 - eurosurveillance.org
Background Surveillance of human leishmaniasis in Europe is mostly limited to country-
specific information from autochthonous infections in the southern part. As at the end of …

[HTML][HTML] Laboratory diagnosis of human visceral leishmaniasis

H Sakkas, C Gartzonika… - Journal of vector borne …, 2016 - journals.lww.com
Visceral leishmaniasis (VL), caused by the Leishmania donovani complex, is a vector-borne
systemic disease, with a worldwide distribution causing high morbidity and mortality in the …

Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships

O Gupta, T Pradhan, R Bhatia, V Monga - European Journal of Medicinal …, 2021 - Elsevier
Leishmaniasis is a parasitic neglected tropical disease caused by various species of
Leishmania parasite. Despite tremendous advancements in the therapeutic sector and drug …

Interventions for American cutaneous and mucocutaneous leishmaniasis

M Pinart, JR Rueda, GAS Romero… - Cochrane Database …, 2020 - cochranelibrary.com
Background On the American continent, cutaneous and mucocutaneous leishmaniasis (CL
and MCL) are diseases associated with infection by several species of Leishmania …

A review of current treatments strategies based on paromomycin for leishmaniasis

APS Matos, AL Viçosa, MI Ré, E Ricci-Júnior… - Journal of Drug Delivery …, 2020 - Elsevier
Leishmaniasis is a neglected disease caused by protozoan parasites of the Leishmania
genus, which affects many people in several countries. This disease has three major clinical …

[HTML][HTML] Compounds from African medicinal plants with activities against selected parasitic diseases: schistosomiasis, trypanosomiasis and leishmaniasis

CV Simoben, F Ntie-Kang, SH Akone… - Natural products and …, 2018 - Springer
Parasitic diseases continue to represent a threat on a global scale, particularly among the
poorest countries in the world. This is particularly because of the absence of vaccines, and …